DK172033B1 - 5-(4-alkoxy-3-polycycloalkyloxy-phenyl)-hexahydro-2-pyrimidinon-derivater,3-(4-alkoxy-3-polycycloalkyloxy-phenyl)glutaramid-derivater anvendelige som mellemprodukter ved deres fremstilling og farmaceutiske præparater til behandling af depression - Google Patents

5-(4-alkoxy-3-polycycloalkyloxy-phenyl)-hexahydro-2-pyrimidinon-derivater,3-(4-alkoxy-3-polycycloalkyloxy-phenyl)glutaramid-derivater anvendelige som mellemprodukter ved deres fremstilling og farmaceutiske præparater til behandling af depression Download PDF

Info

Publication number
DK172033B1
DK172033B1 DK215087A DK215087A DK172033B1 DK 172033 B1 DK172033 B1 DK 172033B1 DK 215087 A DK215087 A DK 215087A DK 215087 A DK215087 A DK 215087A DK 172033 B1 DK172033 B1 DK 172033B1
Authority
DK
Denmark
Prior art keywords
polycycloalkyloxy
alkoxy
phenyl
compounds
formula
Prior art date
Application number
DK215087A
Other languages
Danish (da)
English (en)
Other versions
DK215087D0 (da
DK215087A (da
Inventor
Nicholas Alex Saccomano
Fredric James Vinick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK215087D0 publication Critical patent/DK215087D0/da
Publication of DK215087A publication Critical patent/DK215087A/da
Application granted granted Critical
Publication of DK172033B1 publication Critical patent/DK172033B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
DK215087A 1986-04-29 1987-04-28 5-(4-alkoxy-3-polycycloalkyloxy-phenyl)-hexahydro-2-pyrimidinon-derivater,3-(4-alkoxy-3-polycycloalkyloxy-phenyl)glutaramid-derivater anvendelige som mellemprodukter ved deres fremstilling og farmaceutiske præparater til behandling af depression DK172033B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8600958 1986-04-29
PCT/US1986/000958 WO1987006576A1 (en) 1986-04-29 1986-04-29 Calcium independent camp phosphodiesterase inhibitor antidepressant

Publications (3)

Publication Number Publication Date
DK215087D0 DK215087D0 (da) 1987-04-28
DK215087A DK215087A (da) 1987-10-30
DK172033B1 true DK172033B1 (da) 1997-09-22

Family

ID=22195483

Family Applications (1)

Application Number Title Priority Date Filing Date
DK215087A DK172033B1 (da) 1986-04-29 1987-04-28 5-(4-alkoxy-3-polycycloalkyloxy-phenyl)-hexahydro-2-pyrimidinon-derivater,3-(4-alkoxy-3-polycycloalkyloxy-phenyl)glutaramid-derivater anvendelige som mellemprodukter ved deres fremstilling og farmaceutiske præparater til behandling af depression

Country Status (28)

Country Link
EP (1) EP0247725B1 (hu)
JP (1) JPH0645602B2 (hu)
KR (1) KR900002064B1 (hu)
CN (1) CN1018827B (hu)
AT (1) ATE102189T1 (hu)
AU (1) AU576448B2 (hu)
CA (1) CA1331606C (hu)
CZ (1) CZ280146B6 (hu)
DD (3) DD280319A5 (hu)
DE (1) DE3789164T2 (hu)
DK (1) DK172033B1 (hu)
EG (1) EG18239A (hu)
ES (1) ES2061492T3 (hu)
FI (2) FI94341C (hu)
HU (1) HU215433B (hu)
IE (1) IE63170B1 (hu)
IL (1) IL82342A (hu)
IN (1) IN167587B (hu)
MY (2) MY102842A (hu)
NO (2) NO173138C (hu)
NZ (1) NZ220106A (hu)
PH (1) PH25107A (hu)
PL (1) PL153225B1 (hu)
PT (1) PT84766B (hu)
SU (2) SU1646488A3 (hu)
WO (1) WO1987006576A1 (hu)
YU (4) YU47969B (hu)
ZA (1) ZA873014B (hu)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610531D0 (en) * 1986-04-30 1986-06-04 Fbc Ltd Herbicides
DE3823299A1 (de) * 1988-07-07 1990-01-11 Schering Ag Substituierte phenyl-pyrrolidin-2-one, -oxazolidin-2-one und -imidazolidin-2-one, ihre herstellung sowie verwendung in arzneimitteln
CZ280006B6 (cs) * 1989-11-13 1995-09-13 Pfizer Inc. Způsob přípravy opticky aktivního (2S) nebo (2R)-endobicyklo-2.2.1heptan-2-olu
WO1991007177A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
AU8292091A (en) * 1990-08-03 1992-03-02 Smithkline Beecham Corporation Tnf inhibitors
US5124455A (en) * 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
EP0557408A4 (en) * 1990-11-06 1993-10-27 Smith-Kline Beecham Corporation Imidazolidinone compounds
US5547979A (en) * 1992-03-30 1996-08-20 Smithkline Beecham TNF inhibition
US5395935A (en) * 1992-05-08 1995-03-07 Pfizer Inc. Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
GB9212673D0 (en) * 1992-06-15 1992-07-29 Celltech Ltd Chemical compounds
GB9222253D0 (en) * 1992-10-23 1992-12-09 Celltech Ltd Chemical compounds
CZ141795A3 (en) * 1992-12-02 1995-11-15 Pfizer 4-substituted catechol diethers as such and for treating diseases and pharmaceutical preparations based thereon
US5814651A (en) * 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
GB9226830D0 (en) * 1992-12-23 1993-02-17 Celltech Ltd Chemical compounds
US5622977A (en) * 1992-12-23 1997-04-22 Celltech Therapeutics Limited Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
US5665754A (en) * 1993-09-20 1997-09-09 Glaxo Wellcome Inc. Substituted pyrrolidines
ATE187447T1 (de) * 1993-11-26 1999-12-15 Pfizer 3-phenyl-2-isoxazoline derivate als entzündugshemmende mittel
US5502072A (en) * 1993-11-26 1996-03-26 Pfizer Inc. Substituted oxindoles
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process
EP0738268B1 (en) * 1993-12-22 2004-03-03 Celltech R&D Limited Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
WO1995024398A1 (en) * 1994-03-09 1995-09-14 Pfizer Inc. Isoxazoline compounds as inhibitors of tnf release
WO1995024192A1 (en) * 1994-03-09 1995-09-14 Pfizer Inc. Isoxazoline compounds as 5-lipoxygenase inhibitors
US5786354A (en) * 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
US6245774B1 (en) 1994-06-21 2001-06-12 Celltech Therapeutics Limited Tri-substituted phenyl or pyridine derivatives
GB9412571D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412573D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412672D0 (en) * 1994-06-23 1994-08-10 Celltech Ltd Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
JP2960965B2 (ja) * 1994-08-05 1999-10-12 ファイザー・インコーポレーテッド ５−（３−［エキソビシクロ［２．２．１］ヘプト−２−イルオキシ］−４−メトキシフェニル）−３，４，５，６−テトラヒドロピリミジン−２（１ｈ）−オンの合成の方法および中間体
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
GB9526246D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9526245D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
DE19617864A1 (de) * 1996-04-23 1997-10-30 Schering Ag Neue chirale Phenyldihydrofuranone
GB9608435D0 (en) * 1996-04-24 1996-06-26 Celltech Therapeutics Ltd Chemical compounds
US6294541B1 (en) 1996-06-06 2001-09-25 Euro-Celtique S.A. Purine derivatives having phosphodiesterase IV inhibition activity
DE69730980T2 (de) 1996-07-31 2006-02-23 Nikken Chemicals Co., Ltd. 6-phenyltetrahydro-1,3-oxazin-2-on derivate und medizinische zusammensetzungen, die sie enthalten
CA2264685C (en) 1996-08-27 2002-10-15 Kyoji Noda 2-phenylmorpholin-5-one derivatives and pharmaceutical composition comprising the same
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
US5744473A (en) * 1996-09-16 1998-04-28 Euro-Celtique, S.A. PDE IV inhibitors: "bis-compounds"
GB9622363D0 (en) * 1996-10-28 1997-01-08 Celltech Therapeutics Ltd Chemical compounds
GB9625184D0 (en) * 1996-12-04 1997-01-22 Celltech Therapeutics Ltd Chemical compounds
US6057329A (en) * 1996-12-23 2000-05-02 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives
GB9705361D0 (en) 1997-03-14 1997-04-30 Celltech Therapeutics Ltd Chemical compounds
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
AU1722999A (en) 1997-12-12 1999-07-05 Euro-Celtique S.A. Preparation of 3-substituted adenines and imidazo pyridines
US6319928B1 (en) 1998-11-30 2001-11-20 Euro-Celtique, S.A. Purine derivatives having phosphodiesterase IV inhibition activity
AU4053800A (en) 1999-04-02 2000-10-23 Euro-Celtique S.A. Purine derivatives having phosphodiesterase iv inhibition activity
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
GB9924862D0 (en) 1999-10-20 1999-12-22 Celltech Therapeutics Ltd Chemical compounds
PL367130A1 (en) 2001-05-29 2005-02-21 Schering Aktiengesellschaft Cdk inhibiting pyrimidines, production thereof and their use as medicaments
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
KR100753017B1 (ko) * 2006-05-25 2007-08-30 한국화학연구원 7-(3,4-디알콕시페닐)-피라졸로[1,5-ａ]피리미딘 화합물을포함하는 관절염, 아토피 피부염, 백혈병을 포함한 암 및알쯔하이머, 우울증 또는 기억력 감소 등의 뇌질환의 치료및 예방을 위한 약제학적 조성물
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP3239170B1 (en) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
JP2011144169A (ja) * 2009-12-18 2011-07-28 Ishihara Sangyo Kaisha Ltd イミダゾピリミジン誘導体又はその塩、並びにそれらを含有する有害生物防除剤
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
CN102731411B (zh) * 2012-06-15 2014-10-22 湖南大学 4-烷基-6-芳基-3,4-二氢嘧啶-2-硫酮的制备及其作为抗抑郁药物的应用
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
IL280864B2 (en) 2013-08-09 2024-03-01 Ardelyx Inc Compounds and methods for inhibiting phosphate transport
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1451154A (fr) * 1959-06-22 1966-01-07 Guy Hue Lab Nouveaux dérivés pyrazoliques et leur procédé de préparation
NL136620C (hu) * 1963-04-30
US3923833A (en) * 1968-05-01 1975-12-02 Hoffmann La Roche N-{8 (1-cyano-2-phenyl)ethyl{9 carbamates
BE759176A (fr) * 1969-11-20 1971-05-19 Sandoz Sa Derives de la pyrimidine, leur preparation et medicaments contenant cesderives
US3636039A (en) * 1970-02-24 1972-01-18 Hoffmann La Roche Substituted benzylimidazolidinones
DE2413935A1 (de) * 1974-03-20 1975-10-16 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone
US4193926A (en) * 1974-03-20 1980-03-18 Schering Aktiengesellschaft 4-(Polyalkoxy phenyl)-2-pyrrolidones
IE40911B1 (en) * 1974-04-11 1979-09-12 Schering Ag Imidazole derivatives and process for their manufacture
DE2541855A1 (de) * 1975-09-18 1977-03-31 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone ii
SU888821A3 (ru) * 1976-12-03 1981-12-07 Шеринг Аг (Инофирма) Способ получени 5-(замещенный фенил)-оксазолидинонов или их серусодержащих аналогов
HU179019B (en) * 1978-11-01 1982-08-28 Gyogyszekutato Intezet Process for preparing 4-//3,4-dialkoxy-phenyl/-alkyl/- 2imidazolidinone derivatives
US4261995A (en) * 1979-08-31 1981-04-14 Syntex (U.S.A.) Inc. 4-Phenyl-and 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives
DE3130633A1 (de) * 1981-08-01 1983-02-17 Basf Ag, 6700 Ludwigshafen 7-amino-azolo(1,5-a)pyrimidine und diese enthaltende fungizide
DE3315797A1 (de) * 1983-04-30 1984-10-31 Beiersdorf Ag, 2000 Hamburg Substituierte phenyl-2-(1h)-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
JPS6019789A (ja) * 1983-07-12 1985-01-31 Kyorin Pharmaceut Co Ltd イミダゾ〔１，５−ａ〕ピリミジン誘導体

Also Published As

Publication number Publication date
NO875441D0 (no) 1987-12-28
FI875724A (fi) 1987-12-28
CZ280146B6 (cs) 1995-11-15
FI94341C (fi) 1995-08-25
DK215087D0 (da) 1987-04-28
CN87103225A (zh) 1987-11-11
FI875724A0 (fi) 1987-12-28
EP0247725B1 (en) 1994-03-02
IE871036L (en) 1987-10-29
NZ220106A (en) 1991-08-27
ZA873014B (en) 1988-12-28
CN1018827B (zh) 1992-10-28
NO173138C (no) 1993-11-03
IE63170B1 (en) 1995-03-22
NO173138B (no) 1993-07-26
DD273773A5 (de) 1989-11-29
NO875440L (no) 1987-12-28
DD280319A5 (de) 1990-07-04
YU46916B (sh) 1994-06-24
MY106638A (en) 1995-07-31
EP0247725A3 (en) 1990-01-17
MY102842A (en) 1993-03-31
HUT63150A (en) 1993-07-28
PL265397A1 (en) 1988-07-21
ATE102189T1 (de) 1994-03-15
NO875440D0 (no) 1987-12-28
EG18239A (en) 1992-10-30
AU7214287A (en) 1987-12-10
DK215087A (da) 1987-10-30
WO1987006576A1 (en) 1987-11-05
IN167587B (hu) 1990-11-17
YU115588A (en) 1988-10-31
PT84766A (en) 1987-05-01
JPH0645602B2 (ja) 1994-06-15
CA1331606C (en) 1994-08-23
KR900002064B1 (ko) 1990-03-31
PL153225B1 (en) 1991-03-29
PT84766B (pt) 1989-12-29
YU46915B (sh) 1994-06-24
SU1646488A3 (ru) 1991-04-30
YU47969B (sh) 1996-08-13
YU115688A (en) 1988-10-31
DD280321A5 (de) 1990-07-04
FI875660A (fi) 1987-12-22
IL82342A (en) 1992-03-29
FI94341B (fi) 1995-05-15
KR870010009A (ko) 1987-11-30
ES2061492T3 (es) 1994-12-16
EP0247725A2 (en) 1987-12-02
PH25107A (en) 1991-02-19
SU1653542A3 (ru) 1991-05-30
CZ298987A3 (en) 1995-05-17
FI875660A0 (fi) 1987-12-22
HU215433B (hu) 2000-05-28
YU115788A (en) 1988-10-31
YU47195B (sh) 1995-01-31
DE3789164D1 (de) 1994-04-07
AU576448B2 (en) 1988-08-25
YU77387A (en) 1988-10-31
JPS62281864A (ja) 1987-12-07
DE3789164T2 (de) 1994-06-09

Similar Documents

Publication Publication Date Title
DK172033B1 (da) 5-(4-alkoxy-3-polycycloalkyloxy-phenyl)-hexahydro-2-pyrimidinon-derivater,3-(4-alkoxy-3-polycycloalkyloxy-phenyl)glutaramid-derivater anvendelige som mellemprodukter ved deres fremstilling og farmaceutiske præparater til behandling af depression
US5128358A (en) Aryl substituted nitrogen heterocyclic antidepressants
US7005432B2 (en) Substituted imidazol-pyridazine derivatives
US5767116A (en) Bicyclic aromatic compounds as therapeutic agents
KR100244626B1 (ko) 5-ht1a 길항제로서의 피페라진 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US5294730A (en) Calcium independent camp phosphodiesterase inhibitor antidepressant
US4353901A (en) 9-(1,4-Benzodioxan-2-ylalkyl and hydroxyalkyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-ones
FI76783B (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 2-aminoalkoxi-1,7,7-trimetylbicyklo /2.2.1/heptanderivat.
HU228509B1 (en) Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
US3532712A (en) N'-cyclopropyl ethylenediamine derivatives
JPS58172379A (ja) 新規なキナゾリン誘導体
US4565816A (en) Piperazine derivatives and pharmaceutical composition containing them
NL8303673A (nl) Benzodioxinopyrroolderivaten en werkwijzen voor het bereiden daarvan; farmaceutische preparaten.
EP0113587B1 (en) Pyridine derivatives, process for their preparation and pharmaceutical compositions containing them
SE503227C2 (sv) Substituerade styrenderivat, förfarande för framställning av dessa samt farmaceutiska kompositioner innehållande desamma
US3317538A (en) 4, 4'-diamino-butyrophenones
EP0019866A1 (en) Process for the preparation of 10,11-dihydro-5H-dibenzo (a,d)cyclohepten-5,10-imines
US3433801A (en) 1-aryl-3-(n-lower alkyl amino) pyrrolidines
US6265402B1 (en) Use of 2-phenylmorpholin-5-one derivatives
US2769808A (en) Dioxolane compounds
IE893871L (en) New indole derivatives, process for preparing them and¹pharmaceutical compositions containing them
US4504481A (en) Benzhydrylpiperazine derivatives, process for their preparation and pharmaceutical compositions containing them
US5162321A (en) 1-naphthyl piperazines useful as 5-HT1A receptor ligands
EP0150891A1 (en) Tricyclic compounds, processes for their preparation, compositions containing such compounds and their use in medicine
HRP20010005A2 (en) N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK